Cfo4 Life Group, LLC Novartis Ag Transaction History

Cfo4 Life Group, LLC

  • $528 Million
  • Q2 2024

A detailed history of Cfo4 Life Group, LLC transactions in Novartis Ag stock. As of the latest transaction made, Cfo4 Life Group, LLC holds 5,332 shares of NVS stock, worth $613,286. This represents 0.11% of its overall portfolio holdings.

Number of Shares
5,332
Previous 6,406 16.77%
Holding current value
$613,286
Previous $619,000 8.4%
% of portfolio
0.11%
Previous 0.11%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024
SELL
$92.57 - $107.37 $99,420 - $115,315
-1,074 Reduced 16.77%
5,332 $567,000
Q1 2024

May 06, 2024
SELL
$95.27 - $108.47 $58,019 - $66,058
-609 Reduced 8.68%
6,406 $619,000
Q4 2023

Jan 24, 2024
SELL
$92.27 - $101.54 $12,548 - $13,809
-136 Reduced 1.9%
7,015 $708,000
Q3 2023

Oct 30, 2023
BUY
$94.73 - $105.13 $83,930 - $93,145
886 Added 14.14%
7,151 $728,000
Q2 2023

Aug 07, 2023
BUY
$92.52 - $104.91 $48,387 - $54,867
523 Added 9.11%
6,265 $632,000
Q1 2023

May 03, 2023
SELL
$80.03 - $92.81 $54,340 - $63,017
-679 Reduced 10.57%
5,742 $528,000
Q4 2022

Feb 03, 2023
BUY
$75.55 - $92.52 $65,350 - $80,029
865 Added 15.57%
6,421 $582,000
Q3 2022

Oct 19, 2022
BUY
$74.61 - $87.26 $6,192 - $7,242
83 Added 1.52%
5,556 $422,000
Q2 2022

Jul 20, 2022
SELL
$80.52 - $93.75 $12,802 - $14,906
-159 Reduced 2.82%
5,473 $453,000
Q1 2022

May 02, 2022
SELL
$80.11 - $90.62 $15,701 - $17,761
-196 Reduced 3.36%
5,632 $494,000
Q4 2021

Feb 10, 2022
SELL
$79.7 - $88.13 $28,213 - $31,198
-354 Reduced 5.73%
5,828 $510,000
Q3 2021

Oct 12, 2021
BUY
$81.78 - $95.14 $28,950 - $33,679
354 Added 6.07%
6,182 $506,000
Q2 2021

Jul 14, 2021
SELL
$85.24 - $94.15 $2,045 - $2,259
-24 Reduced 0.41%
5,828 $532,000
Q1 2021

Apr 20, 2021
BUY
$83.5 - $98.47 $16,032 - $18,906
192 Added 3.39%
5,852 $500,000
Q3 2020

Oct 13, 2020
SELL
$82.14 - $91.0 $18,399 - $20,384
-224 Reduced 3.81%
5,660 $492,000
Q2 2020

Jul 15, 2020
BUY
$80.93 - $91.1 $5,422 - $6,103
67 Added 1.15%
5,884 $514,000
Q1 2020

Apr 16, 2020
SELL
$70.67 - $99.01 $13,073 - $18,316
-185 Reduced 3.08%
5,817 $480,000
Q4 2019

Jan 22, 2020
SELL
$84.35 - $95.37 $6,579 - $7,438
-78 Reduced 1.28%
6,002 $568,000
Q3 2019

Nov 01, 2019
SELL
$85.54 - $94.26 $254,481 - $280,423
-2,975 Reduced 32.85%
6,080 $528,000
Q2 2019

Jul 29, 2019
SELL
$75.4 - $92.8 $5,655 - $6,960
-75 Reduced 0.82%
9,055 $827,000
Q1 2019

Apr 22, 2019
SELL
$75.32 - $86.15 $226,788 - $259,397
-3,011 Reduced 24.8%
9,130 $878,000
Q4 2018

Feb 01, 2019
SELL
$73.66 - $82.02 $62,463 - $69,552
-848 Reduced 6.53%
12,141 $1.04 Million
Q3 2018

Oct 25, 2018
SELL
$66.94 - $77.43 $156,572 - $181,108
-2,339 Reduced 15.26%
12,989 $1.12 Million
Q2 2018

Aug 01, 2018
BUY
$64.91 - $73.36 $994,940 - $1.12 Million
15,328 New
15,328 $1.16 Million

Others Institutions Holding NVS

# of Institutions
1,426
Shares Held
138M
Call Options Held
1.48M
Put Options Held
1.54M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $247B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Cfo4 Life Group, LLC Portfolio

Follow Cfo4 Life Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cfo4 Life Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cfo4 Life Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email